Active Ingredient History

NOW
  • Now
Idalopirdine (INN) (code names Lu AE58054,) is a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia. As of October 2013 it is in phase III clinical trials.   Wikipedia

  • SMILES: FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1
  • InChIKey: YBAWYTYNMZWMMJ-UHFFFAOYSA-N
  • Mol. Mass: 398.38
  • ALogP: 4.92
  • ChEMBL Molecule:
More Chemistry
(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine | idalopirdine | luae58054 | lu ae58054 | lu-ae58054

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue